U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market

Renaissance Capital IPO Research7.42K FollowersFollow5ShareSavePlay(5min)CommentsSummaryOne IPO and six SPACs came to market this past week, and one major issuer joined the pipeline as February comes to a close.One large IPO is currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week.Street research is expected for seven companies in the week ahead, and one lock-up period will be expiring. aprott/iStock via Getty Images One IPO and six SPACs came to market this past week, and one major issuer joined the pipeline as February comes to a close. Generate Biomedicines (GENB) priced its IPO at the midpoint toThis article was written byRenaissance Capital IPO Research7.42K FollowersFollowRenaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance International IPO ETF (NYSE: IPOS). Individual investors can get a free overview of the IPO market on www.renaissancecapital.com, and try a free trial of our premium platform, IPO Pro (ipopro.renaissancecapital.com).

Through Renaissance Capital’s pre-IPO research service, institutional investors get an independent opinion, in-depth fundamental analysis, and customizable financial models on all IPOs.